Short answer
Elevance Health (ELV) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Elevance Health announced financial results for the quarter ended September 30, 2026.
Elevance Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Elevance Health announced financial results for the quarter ended September 30, 2026
- Full earnings details, including key metrics and management commentary, appear in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- 3Q operating revenue $50.4B, up 0.7%, while GAAP diluted EPS rose 17.9% to $6.27
- Adjusted diluted EPS $6.99, supported by a $1.85-per-share net non-operating benefit
- FY 2026 guidance raised to at least $22.00 GAAP EPS and $29.00 adjusted EPS
- Health Benefits margin fell to 1.0% as membership declined 487,000 year over year
- Carelon operating gain increased 17% to $0.9B, offsetting weaker Health Benefits profitability
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Elevance Health 8-K filings
Get the next ELV 8-K as it lands
Follow ELV for push alerts, or ask the research agent what this filing means.